Reports

Featured reports

Latest reports

Filter by sub topic

Cancer screening and COVID-19 in Australia 

This report looks at the impact of COVID-19 on cancer screening over the first half of 2020, by presenting the number of screens between January and June 2020, and how these compare to the number of screens over the same period in the previous comparable year. The results show that the impact of COVID-19 was clearest for BreastScreen Australia, with 145,000 fewer screening mammograms performed in January to June 2020 compared to the same period in 2018.

 

COVID-19
This release includes data from the COVID-19 period.

Radiotherapy in Australia 2018–19 

In 2018–19, 74,200 courses of radiotherapy were delivered in Australia. Half of all radiotherapy patients started treatment within 10 days of being assessed as ready for care, and 90% within 27 days. For those who needed emergency treatment (1.5% of courses), 96% began treatment within the recommended timeframe—on the same or the next day.

Mesothelioma in Australia 2019 

Mesothelioma in Australia 2019 – infocus presents the latest available information on the incidence of mesothelioma in Australia, along with mortality and asbestos exposure information, using data from the Australian Mesothelioma Registry, the National Mortality Database and the Australian Cancer Database. On average, two people are diagnosed with mesothelioma in Australia each day – with a median age at diagnosis of 75 years old. 

National Bowel Cancer Screening Program: monitoring report 2020 

This report presents statistics on the National Bowel Cancer Screening Program (NBCSP) using key performance indicators. Of those who were invited to participate in the NBCSP between 1 January 2017 and 31 December 2018, 42% undertook screening. For those who screened in 2018, 7% had a positive result warranting further assessment. One in 30 participants who underwent a follow-up diagnostic assessment was diagnosed with a confirmed or suspected cancer.

National cancer screening programs participation data 

Cancer screening programs aim to reduce illness and death from selected cancers. This report presents the latest cancer screening participation rates and trends for Australia’s 3 national cancer screening programs. Participation rates are presented for Australia, states and territories, the 31 Primary Health Network areas, and for more than 300 smaller local areas (SA2s and SA3s) across Australia. New activity data for the National Bowel Cancer Screening Program are also presented.

See the Notes section for information on the latest updates to this web report.

Mesothelioma in Australia 2018: occupational asbestos exposure 

This Infocus report presents information on occupational asbestos exposure in Australia, using data from the Australian Mesothelioma Registry (AMR). Mesothelioma patients recorded on the AMR can complete a voluntary asbestos exposure assessment to determine the circumstances of potential past exposure. This report presents results for the three most commonly assigned job-specific modules (or ‘categories’) – ‘Trades’, ‘Land transport’ and ‘Water transport’.

Analysis of cervical cancer and abnormality outcomes in an era of cervical screening and HPV vaccination in Australia 

This is the third report from an Australian-first project, combining screening, cancer, death, and HPV vaccination data to demonstrate the effects of screening and HPV vaccination on cervical cancer, precancerous abnormalities and cervical screening behaviour.
Screen-detected cervical cancers were less likely to cause death than those diagnosed in never-screened women, and HPV-vaccinated women were more likely to participate in cervical screening, and less likely to have a high-grade abnormality.

Mesothelioma in Australia 2018 

This In focus presents the latest available information on the incidence of mesothelioma in Australia, along with mortality and asbestos exposure information, using data from the Australian Mesothelioma Registry, the National Mortality Database and the Australian Cancer Database. On average, two people are diagnosed with mesothelioma in Australia each day.

Cervical screening in Australia 2019 

This is the last monitoring report (to 30 June 2017) for the previous ‘Pap test-based’ National Cervical Screening Program, which ceased on 30 November 2017. For women aged 20–69, participation was estimated at 54%–56%, 7 out of every 1,000 women screened had a high-grade abnormality detected before possible progression to cervical cancer, there were 9–10 new cases per 100,000 women, and there were 2 deaths per 100,000 women.

BreastScreen Australia data dictionary: version 1.2 

BreastScreen Australia aims to reduce illness and death resulting from breast cancer through organised screening to detect cases of unsuspected breast cancer in women, thus enabling early intervention. The BreastScreen Australia Data Dictionary is intended to be the authoritative source of data definitions used by BreastScreen Australia to meet the need for national consistency in data collected for program monitoring and evaluation, and for accreditation of BreastScreen Australia services.

Cancer in Australia 2019: in brief 

In 2019, the rate of new cancer cases in Australia is expected to reach 483 new cases per 100,000 people, while cancer-related deaths are expected to decrease to 159 per 100,000 people. From 1982 to 2019, thyroid cancer and liver cancer incidence rates increased more than for any other cancer. Although liver cancer survival has improved since 1982, with the increasing liver cancer incidence rate, liver cancer mortality rates also increased more than those for any other cancer. 

Analysis of breast cancer outcomes and screening behaviour for BreastScreen Australia 

This is the second report from an Australian-first project combining data from BreastScreen Australia, the National Cervical Screening Program and the National Bowel Cancer Screening Program, focusing on breast cancer outcomes and screening behaviour in BreastScreen Australia. It was found that screen-detected breast cancers were less likely to cause death than never-screened breast cancers for all age groups eligible to screen in BreastScreen Australia, with analyses giving new insights into screening behaviour.

Mesothelioma in Australia 2017 

Mesothelioma in Australia – infocus presents the latest available information on the incidence of mesothelioma in Australia, along with mortality and information on previous asbestos exposure, using data from the Australian Mesothelioma Registry (AMR), the National Mortality Database (NMD) and the Australian Cancer Database (ACD). On average, two people are diagnosed with mesothelioma in Australia each day.

Colorectal and other digestive-tract cancers 

Digestive-tract cancers are estimated to account for about 2 in 10 of all cancers diagnosed and nearly 3 in 10 cancer deaths. A person’s chance of surviving depends on the type of digestive-tract cancer: colorectal cancer (the most common digestive-tract cancer) had the highest 5-year relative survival rate (69%), while pancreatic cancer (the second most common digestive-tract cancer) had the lowest 5-year relative survival of all specified digestive cancers (8.7%).